ABBOTT LABORATORIES
ABBOTT LABORATORIES (ABT) is a publicly traded company in the Unknown sector. Across all available filings, 54 corporate insiders have executed 1012 transactions totaling $504.4M, demonstrating a bearish sentiment with -$499.1M in net insider flow. The most recent transaction on Jan 23, 2026 involved a purchase of 18,800 shares valued at $2.0M.
ABT Insider Activity Summary
Who Is Buying ABT Stock?
No significant insider buying has been recorded for ABT in the recent period.
Who Is Selling ABT Stock?
No significant insider selling has been recorded for ABT in the recent period.
Is ABBOTT LABORATORIES Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ABT is bearish with an Insider Alignment Score of 1/100 and a net flow of -$499.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ABT Frequently Asked Questions
Understanding ABT Insider Activity
Insider trading at ABBOTT LABORATORIES (ABT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 54 insiders are actively trading ABT stock, having executed 1012 transactions in the past 90 days. The most active insider is Brian B. Yoor (Executive), who has made 14 transactions totaling $76.6M.
Related Tools
Track ABBOTT LABORATORIES Insider Activity
Get notified when executives and directors at ABT file new Form 4 transactions